JPRN-UMIN000020295
Completed
未知
A Study on Predictors of Treatment Response to Simeprevir, Peg-interferon and Ribavirin combination therapyin Patients with genotype Chronic Hepatitis C Virus Infection - Predictors of treatment response to SMV/Peg-IFN/RBV therapy
ConditionsPatients with genotype 1 HCV infection
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Patients with genotype 1 HCV infection
- Sponsor
- Hokkaido University
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with poorly controlled cardiac disease (e.g., myocardial infarction, cardiac failure, arrhythmia) 2\)Patients with severe hepatic impairment 3\)Patients with a history of hypersensitivity to HCV protease inhibitors or Ribavirin 4\)Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5\)Patients deemed unsuitable for study entry by their treating physician 6\) Patients with severe renal dysfunction 7\)Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A Study on Predictors of Treatment Response to Sofosbuvir and Ribavirin Therapy in Patients with genotype 2 Chronic Hepatitis C Virus InfectioPatients with genotype 2 HCV infectionJPRN-UMIN000018947Hokkaido University Department of Gastroenterology and Hepatology, Graduate School of Medicine,260
Completed
Not Applicable
A Study on Predictors of Treatment Response to Sofosbuvir and Ledipasvir Therapy in Patients with genotype 1 Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000019011Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University260
Recruiting
Not Applicable
A prospective study of treatment response of patients with myelofibrosis and PNH type blood cellsmyelofibrosisJPRN-UMIN000045859Juntendo University100
Completed
Not Applicable
A Study on Predictors of Treatment Response to ombitasvir/paritaprevir/r combination therapy in Patients with genotype 1 Chronic Hepatitis C Virus InfectioPatients with genotype 1 HCV infectionJPRN-UMIN000020299Hokkaido University260
Completed
Not Applicable
Studies on the predictive factors of treatment outcome after intravitreal injection of Lucentis (ranibizumab) in eyes with macular edema associated with central retinal vein occlusion (CRVO)Central retinal vein occlusionJPRN-UMIN000012793Ophthalmology, Mie University Hospital30